+49 1609 6566117
info@atlasbion.com
  • HOME
  • ABOUT
    • About Us
  • PRODUCTS
    • Specific Reagents
    • Dedicated Reagents
    • Supplementary Reagents
    • Calibrators-Controls-Standard
    • Instruments
      • Refurbished Equipments
      • Spare Parts
    • Software
  • TRAINING
  • SERVICES
  • CONTACT
  • Register/LogIn
    • Account
My Account
Log Out
Fill out this field
Fill out this field
Product has been added to your cart.

FDA approval brings remote programming for Abbott’s deep brain stimulation device

news
4 years ago
Abbott announced the launch of the newly-approved NeuroSphere Virtual Clinic by which deep brain stimulation patients can have their devices programmed and reset remotely, from the comfort of their homes…

Beckman Coulter seeks authorization for $4 antigen test

news
4 years ago
As the Department of Health and Human Services purchases more of Abbott’s rapid antigen tests, competitor Beckman Coulter said it is seeking an emergency use authorization for its $4 antigen…

Lucira Covid-19 test is first to get FDA nod for home use

news
5 years ago
The authorization comes as Covid-19 testing demand threatens to swamp U.S. labs. However, it will take time for the Lucira test to become available nationwide. Read more

Medicare to cover all FDA-approved Covid-19 vaccines

news
5 years ago
CMS’ interim rule states that Medicare will cover Covid-19 vaccines approved by the FDA, including those receiving emergency use authorization, in a reversal from its usual policy. The vaccine will…

Covid-19’s digital imperative for biopharma and medtech

news
5 years ago
The disruption to biopharma and medtech businesses caused by Covid-19, from sales rep visits with doctors, product launch and clinical trial delays has underscored the need for a more digital…

Algorithm that predicts Covid-19 complications gets EUA

news
5 years ago
The FDA granted an emergency use authorization to an algorithm developed by Dascena to predict which Covid-19 patients might face unstable blood pressure or respiratory decline. Read more

DoD tests wearables’ ability to detect Covid-19 before symptoms appear

news
5 years ago
Long before the start of the Covid-19 pandemic, the U.S. Department of Defense and Royal Philips had been working on a project to detect potential outbreaks of infectious disease before…

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief

news
5 years ago
AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot, despite clinical trials being paused…

Pfizer, Germany’s BioNTech release new data on Covid-19 vaccine

news
5 years ago
Early clinical trial data from a Covid-19 vaccine that is among those currently in late-stage testing have shown favorable responses among participants in terms of antibody and immune cell responses.…

Roche begins trial of Actemra/RoActemra plus remdesivir

news
5 years ago
Roche has launched a Phase III study in collaboration with Gilead to evaluate the safety and efficacy of Actemra/RoActemra (tocilizumab) in combination with remdesivir in hospitalised patients with severe COVID-19…
This website uses cookies to improve your experience. If you continue to use this site, you agree with it.